市場調查報告書
商品編碼
1410898
重建網格市場:市場規模(按細分市場)、份額、監管、報銷、程序、預測(~2033)Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
重建網是一種可透過手術植入的編織片,用於修復或支撐器官和其他組織。 該網是由合成材料和/或動物組織生物工程製成的。 由於患者滿意度的提高、成本的降低以及手術副作用的減少,乳房再造市場正在急劇擴大。 修復網與乳房植入物的結合使用正在成為乳房切除術後乳房重建的有效方法。 由於美觀效果的改善,未來 IBBR(基於植入物的乳房重建)手術中使用合成和生物網片的需求可能會增加。 合成網在乳房重建、骨盆腔器官脫垂治療和尿失禁治療的安全性和性能的持續改進可能有助於整體市場價值的擴張。
本報告深入探討了全球重建網市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。
Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond. Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. The breast reconstruction market is increasing dramatically due to improvements in patient satisfaction, reduced costs, and decreases in side-effects from procedures. Use of repair meshes along with breast implants is emerging as an effective method for breast reconstruction after mastectomy. The demand for the use of synthetic and biologic meshes in IBBR (Implant based Breast Reconstruction) surgeries is likely to increase in the future because of the improved aesthetic outcome. Continued improvements in synthetic mesh safety and performance for breast reconstruction, pelvic organ prolapse treatment, and urinary incontinence treatments will contribute to their overall growth in market value.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Reconstruction Meshes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: AbbVie Inc, W. L. Gore & Associates Inc, Donor Network West, Surgalign Holdings Inc, Coloplast A/S, Johnson & Johnson, Boston Scientific Corp, Becton Dickinson and Co, Integra LifeSciences Holdings Corp, pfm medical ag, Baxter International Inc, LifeNet Health Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable